This review surveys a wide range of cellular and molecular approaches to st
rengthening the injured or weakened heart, focusing on strategies to replac
e dysfunctional, necrotic, or apoptotic cardiomyocytes with new cells of me
sodermal origin. A variety of cell types, including myogenic cell lines, ad
ult skeletal myoblasts, immortalized atrial cells, embryonic and adult card
iomyocytes, embryonic stem cells, teratoma cells, genetically altered fibro
blasts, smooth muscle cells, and bone marrow-derived cells have all been pr
oposed as useful cells in cardiac repair and may have the capacity to perfo
rm cardiac work. We focus on the implantation of mesodermally derived cells
, the best developed of the options. We review the developmental and cell b
iology that have stimulated these studies, examine the limitations of curre
nt knowledge, and identify challenges for the future, which we believe are
considerable.